QLS5212 / Qilu Pharma - LARVOL DELTA

QLS5212 for Participants With Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=100 | Recruiting | Sponsor: Qilu Pharmaceutical Co., Ltd. | Not yet recruiting ➔ Recruiting

Enrollment open • First-in-human • Monotherapy • Oncology • Solid Tumor